Given the fact that POLQ is overexpressed in ESCC and is associated with poor clinical outcome, we postulated that the upregulated expression of POLQ may allow ESCC cells to better tolerate the increasing replication stress caused by uncontrolled proliferation or anti-cancer drugs and, therefore, promote the cancer progression. The gene discussed is POLQ; the disease is cancer.